XML 88 R69.htm IDEA: XBRL DOCUMENT v3.25.4
Ordinary Shares - Additional Information (Details)
12 Months Ended
Nov. 06, 2023
GBP (£)
Apr. 21, 2021
Dec. 31, 2025
vote
Subsidiary, Sale of Stock [Line Items]      
Number of votes per common share (in votes) | vote     1
Percentage of ordinary shares present to exercise preemptive rights     75.00%
Maximum period to exercise preemptive rights     5 years
Maximum aggregate nominal amount of shares authorized to be allotted free from pre-emption rights | £ £ 1,928    
IPO      
Subsidiary, Sale of Stock [Line Items]      
Maximum period to exercise preemptive rights 5 years 5 years 5 years